Nora Therapeutics
Palo Alto, US · Delaware corporation · 2 employees on LinkedIn
Founders & leadership
JK
Jeffrey K. TongExecutive
Board
CY
Chen YuBoard director
DS
David SchnellBoard director
MV
Martin VogelbaumBoard director
AD
Anupam DalalBoard director
BE
Bryant E. FongBoard director
JL
Joseph L. Turner, Jr.Board director
DF
Dennis FentonBoard director
DH
Donald Hayden, Jr.Board director
DJ
Donald J. Hayden, Jr.Board director
Reported raises · per SEC filings
Form D private placements$19M disclosed across 2 of 3 rounds · 2014–2015
▶$1MraisedOct 2015 · 6 investors · BiotechnologyRule 506(b)
▶$1MraisedOct 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph L. Turner, Jr.Director
- Chen YuDirector
- David SchnellDirector
- Dennis FentonDirector
- Donald Hayden, Jr.Director
- Martin VogelbaumDirector
- Jeffrey K. TongExecutive Officer, Director
- Anupam DalalDirector
- Offering amount
- $3M
- Amount sold
- $1M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$536.7KofferedMay 2015 · 1 investors · BiotechnologyRule 506(b)
▶$536.7KofferedMay 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anupam DalalDirector
- David SchnellDirector
- Chen YuDirector
- Dennis FentonDirector
- Joseph L. Turner, Jr.Director
- Jeffrey K. TongExecutive Officer, Director
- Martin VogelbaumDirector
- Donald J. Hayden, Jr.Director
- Offering amount
- $536.7K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MraisedApr 2014 · 6 investors · BiotechnologyRule 506(b)
▶$18MraisedApr 2014 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald J. Hayden, Jr.Director
- Martin VogelbaumDirector
- Bryant E. FongDirector
- Chen YuDirector
- Dennis FentonDirector
- David SchnellDirector
- Jeffrey K. TongExecutive Officer, Director
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nora Therapeutics raised?
- Nora Therapeutics has disclosed $19M raised across 2 of its 3 known rounds.
- Where is Nora Therapeutics headquartered?
- Nora Therapeutics is headquartered in Palo Alto, US.